GT Biopharma Inc (GTBP)

[BullsOnFire]

The economic impact of cancer is significant and is increasing. The total annual economic cost of cancer in 2015 was estimated at approximately US$ 2.5 trillion...Although the economic burden of each cancer case in the United States, the United Kingdom, and Japan ranges between $183-$460 per patient every year, in South America, India, and China it ranges a paltry $0.54-$7.92 per patient. Overall, high-income regions spend 5-10 times more on cancer control on a per capita basis than low- and middle-income countries.

There'a massive opportunity here in $GTBP